Wanfu Lin
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Changquan Ling (16 shared papers)Binbin Cheng (11 shared papers)Shufang Liang (10 shared papers)Chen Wang (3 shared papers)Shu Li (6 shared papers)Huan Wang (3 shared papers)Wentao Jia (5 shared papers)Juan Du (4 shared papers)
In The Last Decade
Wanfu Lin
24 papers receiving 455 citations
Peers
Comparison fields: 5 of 69
- Toxicology 31
- Cancer Research 88
- Complementary and alternative medicine 41
- Pharmacology 38
- Hepatology 27
Countries citing papers authored by Wanfu Lin
This map shows the geographic impact of Wanfu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanfu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanfu Lin more than expected).
Fields of papers citing papers by Wanfu Lin
This network shows the impact of papers produced by Wanfu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanfu Lin. The network helps show where Wanfu Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Wanfu Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 70 | |
| 2 | 2023 | 54 | |
| 3 | 2018 | 35 | |
| 4 | 2017 | 35 | |
| 5 | 2019 | 34 | |
| 6 | 2019 | 30 | |
| 7 | 2018 | 25 | |
| 8 | 2021 | 23 | |
| 9 | 2016 | 21 | |
| 10 | 2018 | 15 | |
| 11 | 2024 | 15 | |
| 12 | 2021 | 14 | |
| 13 | 2024 | 14 | |
| 14 | 2025 | 13 | |
| 15 | 2017 | 12 | |
| 16 | 2023 | 12 | |
| 17 | 2019 | 11 | |
| 18 | 2015 | 9 | |
| 19 | 2018 | 8 | |
| 20 | 2022 | 4 |
About Wanfu Lin
Wanfu Lin is a scholar working on Cancer Research, Complementary and alternative medicine, Analytical Chemistry, Toxicology and Molecular Biology, having authored 26 papers that have together received 461 indexed citations. Recurring topics across this work include Phytochemistry and biological activity of medicinal plants (3 papers), Chromatography in Natural Products (3 papers), Extracellular vesicles in disease (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Immune cells in cancer (2 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Toxicology (31 citations), Cancer Research (88 citations), Complementary and alternative medicine (41 citations), Pharmacology (38 citations) and Hepatology (27 citations). Wanfu Lin has collaborated with scholars based in China and Taiwan. Frequent co-authors include Changquan Ling, Binbin Cheng, Shufang Liang, Chen Wang, Shu Li, Huan Wang, Wentao Jia, Juan Du, Jiaying Yuan and Xiaofeng Zhai. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Journal of Chinese Integrative Medicine, Oncology Reports, Journal of Ethnopharmacology and Phytomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.